AI readiness in pharma: Getting the foundation right
AI readiness in pharma depends on data, not just AI. Read how real‑world data and interoperability enable scalable evidence generation.
Narasimha Kumar, Global Head of Technology and Data Services at BC Platforms, has authored a new article published in MedNous. In “How data from medical practice can inform care,” Kumar explores why traditional views of standard of care often lag behind how patients are actually treated — and how real‑world data is changing that. The article also examines how advances in analytics and AI are helping pharma teams turn complex clinical data into actionable insights, supporting better decisions on trial design and evidence generation across the drug lifecycle.
Read the full article below: